Development of a Patient-reported Outcome Measure for Women With Chronic Pelvic Pain (PROM for CPP)
Development of a Patient-reported Outcome (PRO) Measure for Women With Chronic Pelvic Pain (CPP)
Sponsor: Evidera
Listed as NCT06083597, this observational or N/A phase trial focuses on Chronic Pelvic Pain Syndrome and Pelvic Congestive Syndrome and remains ongoing. Sponsored by Evidera, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Enrolling By Invitation
-
Mar 2025 — Jan 2026 [monthly]
Enrolling By Invitation
-
Oct 2024 — Mar 2025 [monthly]
Enrolling By Invitation
-
Sep 2024 — Oct 2024 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
▶ Show 1 earlier version
-
Nov 2023 — Jul 2024 [monthly]
Enrolling By Invitation
First recorded
Jul 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Evidera
- Society of Interventional Radiology Foundation
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .